ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,747.09
0.03%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Arbutus Biopharma Corporation (ABUS) Share Price

ABUS Arbutus Biopharma Corporation

3.33
0.01 (0.30%)
01 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Arbutus Biopharma Corporation NASDAQ:ABUS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.01 0.30 3.33 3.29 3.36 3.385 3.31 3.32 831,299 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 18.14M -72.85M -0.4059 -8.28 603.09M
 Type  Size  Price  Time  Units 
 20 100 3.33 23:40:48 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ABUS News
29/05/202412:30GLOBEArbutus to Participate in Jefferies Global Healthcare Conference
28/05/202421:25EDGAR2Form 8-K - Current report
24/05/202421:10EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
24/05/202421:07EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
22/05/202411:00EDGAR2Form 8-K - Current report
22/05/202407:00GLOBEArbutus to Present Imdusiran Data at EASL Congress 2024
17/05/202414:03EDGAR2Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
23/10/201216:31PBBABUSE3
19/07/200617:49PBBFED UP WITH LIARS ON ADVFN12
Data Downloads for ABUS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Arbutus Biopharma Corporation Articles